Limited efficacy of daratumumab in multiple myeloma with extramedullary disease.
Leukemia
; 36(1): 288-291, 2022 01.
Article
in En
| MEDLINE
| ID: mdl-34247197
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Plasma Cells
/
Clone Cells
/
Antibodies, Monoclonal
/
Multiple Myeloma
/
Antineoplastic Agents
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Leukemia
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2022
Document type:
Article
Affiliation country:
Czech Republic